THE EFFICACY OF MESNA (2-MERCAPTOETHANE SODIUM-SULFONATE) AS A UROPROTECTANT IN PATIENTS WITH HEMORRHAGIC CYSTITIS RECEIVING FURTHER OXAZAPHOSPHORINE CHEMOTHERAPY

被引:43
作者
ANDRIOLE, GL
SANDLUND, JT
MISER, JS
ARASI, V
LINEHAN, M
MAGRATH, IT
机构
[1] NCI,PEDIAT BRANCH,BLDG 10,ROOM 13N240,BETHESDA,MD 20892
[2] NCI,DIV CANC TREATMENT,SURG BRANCH,BETHESDA,MD 20892
关键词
D O I
10.1200/JCO.1987.5.5.799
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:799 / 803
页数:5
相关论文
共 25 条
[1]
IFOSFAMIDE - PHARMACOLOGY, SAFETY AND THERAPEUTIC POTENTIAL [J].
BRADE, WP ;
HERDRICH, K ;
VARINI, M .
CANCER TREATMENT REVIEWS, 1985, 12 (01) :1-47
[3]
THE DEVELOPMENT OF MESNA FOR REGIONAL DETOXIFICATION [J].
BROCK, N ;
POHL, J .
CANCER TREATMENT REVIEWS, 1983, 10 :33-&
[4]
STUDIES ON THE UROTOXICITY OF OXAZAPHOSPHORINE CYTOSTATICS AND ITS PREVENTION .3. PROFILE OF ACTION OF SODIUM 2-MERCAPTOETHANE SULFONATE (MESNA) [J].
BROCK, N ;
POHL, J ;
STEKAR, J ;
SCHEEF, W .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (12) :1377-&
[5]
STUDIES ON THE UROTOXICITY OF OXAZAPHOSPHORINE CYTOSTATICS AND ITS PREVENTION .2. COMPARATIVE-STUDY ON THE UROPROTECTIVE EFFICACY OF THIOLS AND OTHER SULFUR-COMPOUNDS [J].
BROCK, N ;
POHL, J ;
STEKAR, J .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (11) :1155-1163
[6]
DETOXIFICATION OF UROTOXIC OXAZAPHOSPHORINES BY SULFHYDRYL COMPOUNDS [J].
BROCK, N ;
POHL, J ;
STEKAR, J .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1981, 100 (03) :311-320
[7]
PHARMACOKINETICS AND MECHANISM OF ACTION OF DETOXIFYING LOW-MOLECULAR-WEIGHT THIOLS [J].
BROCK, N ;
HILGARD, P ;
POHL, J ;
ORMSTAD, K ;
ORRENIUS, S .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1984, 108 (01) :87-97
[8]
BRYANT BM, 1980, LANCET, V2, P657
[9]
THE USE OF SODIUM 2-MERCAPTOETHANE SULFONATE TO PREVENT CYCLOPHOSPHAMIDE CYSTITIS [J].
EHRLICH, RM ;
FREEDMAN, A ;
GOLDSOBEL, AB ;
STIEHM, ER .
JOURNAL OF UROLOGY, 1984, 131 (05) :960-962
[10]
FAIRCHILD NV, 1939, J UROL, V122, P163